Steadybase.

Ascend Wellness Holdings, Inc.

Website Investor relations LinkedIn Latest 10-K
  • AAWH · OTC
  • Medicinal Chemicals & Botanical Products
  • Rochelle Park, NJ
  • 2,300 employees
  • CIK 0001756390

Updated from SEC filings through

Top things to know

Executives

What leadership is saying

“Last quarter, we said we believed we’d reached an important inflection point. This quarter’s performance confirms it”

Sam Brill, CEO & Director of AWH
Earnings press release (8-K Ex. 99.1), filed August 12, 2026

Ascend Wellness Holdings, Inc. is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Rochelle Park, NJ. It trades as AAWH on OTC. Revenue was $501M in the fiscal year ending December 31, 2025, -10.9% from the year before. It reported about 2,300 employees. Samuel Brill is Chief Executive Officer and Director.

Five-year financials

MetricFY2025FY2024FY2023FY2022FY2021
Revenue $501M
10-K, 2026-03-12
$562M
10-K, 2026-03-12
$519M
10-K, 2026-03-12
$406M
10-K, 2025-03-13
$332M
10-K, 2024-03-13
Operating income -$17.0M
10-K, 2026-03-12
$4.7M
10-K, 2026-03-12
-$3.6M
10-K, 2026-03-12
-$7.5M
10-K, 2025-03-13
-$17.2M
10-K, 2024-03-13
SG&A $170M
10-K, 2026-03-12
$179M
10-K, 2026-03-12
$159M
10-K, 2026-03-12
$137M
10-K, 2025-03-13
$117M
10-K, 2024-03-13
Net income -$118M
10-K, 2026-03-12
-$85.0M
10-K, 2026-03-12
-$48.2M
10-K, 2026-03-12
-$80.9M
10-K, 2023-03-15
-$123M
10-K, 2023-03-15

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Samuel Brill Chief Executive Officer and Director 10-K, 2026-03-12
Roman Nemchenko Chief Financial Officer 10-K, 2026-03-12
Francis Perullo President and Director 10-K, 2026-03-12

What Ascend Wellness Holdings, Inc. does

Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator focused on operating in adult-use or near-term adult-use states in primarily limited license markets. Ascend’s core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which are sold through company-owned retail stores, to retail partner locations, and third-party licensed retail locations. The Company is a reporting issuer in the United States and in each of the provinces and territories of Canada.

Item 1. Business, 10-K for the year ending December 31, 2025

Shares and governance

Shares outstanding 203.2 million (as of August 10, 2026) 10-Q, August 12, 2026
Public float $54.8M (as of June 30, 2025) 10-K, March 12, 2026
Reportable segments 1 (period ending June 30, 2026) 10-Q, August 12, 2026
Latest proxy statement Meeting August 28, 2026 (filed July 9, 2026) DEF 14A, July 9, 2026
Auditor WithumSmith+Brown, PC (New York, New York) Latest 10-K

Recent 8-K events

Frequently asked questions about Ascend Wellness Holdings, Inc.

What does Ascend Wellness Holdings, Inc. do?
In its own words, from Item 1 of its 10-K: "Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator focused on operating in adult-use or near-term adult-use states in primarily limited license markets. Ascend’s core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which are sold through company-owned retail stores, to retail partner locations, and third-party licensed retail locations. The Company is a reporting issuer in the United States and in each of the provinces and territories of Canada."
What is Ascend Wellness Holdings, Inc.'s revenue?
$501M for the fiscal year ending December 31, 2025, from its 10-K filed March 12, 2026.
Is Ascend Wellness Holdings, Inc. profitable?
Ascend Wellness Holdings, Inc. reported net income of -$118M for the fiscal year ending December 31, 2025.
How many employees does Ascend Wellness Holdings, Inc. have?
About 2,300 as of December 31, 2025, as stated in its annual report.
Who is the CEO of Ascend Wellness Holdings, Inc.?
Samuel Brill, Chief Executive Officer and Director, as named in a 10-K filed March 12, 2026.
Who is the CFO of Ascend Wellness Holdings, Inc.?
Roman Nemchenko, Chief Financial Officer, as named in a 10-K filed March 12, 2026.
Where is Ascend Wellness Holdings, Inc. headquartered?
Rochelle Park, NJ.
What is Ascend Wellness Holdings, Inc.'s stock ticker?
AAWH on OTC.
What industry is Ascend Wellness Holdings, Inc. in?
Medicinal Chemicals & Botanical Products, SIC code 2833.
What is Ascend Wellness Holdings, Inc.'s website?
awholdings.com. Investor relations: https://investors.awholdings.com/.
When does Ascend Wellness Holdings, Inc. report earnings next?
November 12, 2026 at 17:00. Source: ir_events_fc.
Is Ascend Wellness Holdings, Inc. a public company?
Yes. Ascend Wellness Holdings, Inc. files with the SEC under CIK 0001756390 and trades as AAWH.
Who audits Ascend Wellness Holdings, Inc.?
WithumSmith+Brown, PC, New York, New York, as named in its latest annual report (10-K).
How many shares of Ascend Wellness Holdings, Inc. are outstanding?
203.2 million shares as of August 10, 2026, from its 10-Q filed August 12, 2026.
What is Ascend Wellness Holdings, Inc.'s public float?
$54.8M as of June 30, 2025, as reported on the cover of its 10-K filed March 12, 2026.
How many business segments does Ascend Wellness Holdings, Inc. report?
1 reportable segment for the period ending June 30, 2026, from its 10-Q filed August 12, 2026.
When is Ascend Wellness Holdings, Inc.'s annual shareholder meeting?
August 28, 2026, per its proxy statement (DEF 14A) filed July 9, 2026.